experts evaluate the progress of the CRIC Study

External Expert Panel

An independent group of experts in areas such as nephrology, cardiology, preventive medicine, epidemiology, nutrition, ethics, health economics, and biostatistics who are not otherwise involved in the study have been recruited by the NIDDK to evaluate the proposed protocol for all phases of the CRIC Study and to periodically review the progress of the study.

The individuals listed below are members of the External Expert Panel for phase III of CRIC.

Paul M. Palevsky, MD

Acting Chair of the Panel
Chief, Renal Section
VA Pittsburgh Healthcare System
Professor of Medicine and Clinical & Translational Science
University of Pittsburgh School of Medicine

David T. Gilbertson, PhD

Executive Director of Epidemiology and Biostatistics
United States Renal Data System

Peter A. McCullough, MD, MPH

Consultant Cardiologist
Chief, Academic and Scientific Officer
St. John Providence Health System

David Nathan, MD

Director, Massachusetts General Hospital Diabetes Center
Professor of Medicine
Harvard Medical School
Massachusetts General Hospital

Ann M. O'Hare, MD

Associate Professor of Medicine
Division of Nephrology
University of Washington
VA Puget Sound Health Care

Stephen S. Rich, PhD

Director, Center for Public Health Genomics
Harrison Professor & Vice Chair
Department of Public Health Sciences
University of Virginia

Richard D. Toto, MD

Associate Dean, Translational Science
Mary M. Conroy Professorship in Kidney Disease
Department of Medicine
Division of Nephrology
UT Southwestern Medical Center at Dallas

Gina S. Wei, MD, MPH

Medical Officer
Epidemiology Branch
Prevention and Population Sciences Program
Division of Cardiovascular Sciences
National Heart, Lung and Blood Institute

Peter W. Wilson, MD

Emory University School of Medicine
Department of Medicine, Cardiology Division

The individuals listed below served as members of the Scientific Advisory Committee for the first two phases of CRIC.

William McClellan, MD, MPH

Chairman of the SAC
Emory University

Bryce A. Kiberd, MD

Queen Elizabeth II Health Science Centre-VG Site

Kathy Faber-Langendoen, MD

Chair
Center for Bioethics & Humanities
SUNY Upstate Medical University

Elisa T. Lee, PhD

George Lynn Cross Professor and Director
Center for American Indian Health Research
University of Oklahoma Health Sciences Center
College of Public Health

Julia Lewis, MD

Professor of Medicine
Vanderbilt University Medical Center

Timothy Meyer, MD

Palo Alto VA Medical Center

David M. Nathan, MD

Director, Massachusetts General Hospital Diabetes Center
Professor of Medicine
Harvard Medical School

John B. Stokes, MD

Department of Internal Medicine
Division of Nephrology
University of Iowa

Herman Taylor, MD, FACC

Director, Jackson Heart Study
University of Mississippi

Peter W. Wilson, M.D.

Emory University School of Medicine
Department of Medicine, Cardiology Division

CRIC Scientific Discoveries

FGF23 elevation has been linked to greater risks of left ventricular hypertrophy (LVH) and mortality in patients with chronic kidney disease (CKD), but whether these risks represent causal effects of FGF23 is unknown. Here, we report that elevated FGF23 levels are independently associated with prevalent and incident LVH among CRIC Study participants.
Learn more >>

CRIC Collaborations

The CRIC Scientific and Data Coordinating Center at Penn receives data and provides ongoing support for a number of Ancillary Studies approved by the CRIC Cohort utilizing both data collected about CRIC study participants as well as their biological samples.
Learn more about collaborating with CRIC >>
Copyright © 2012-2017 Chronic Renal Insufficiency Cohort Study || Site Map